GeneOhm Sciences, Inc. And The Cleveland Clinic Foundation Announce The Completion Of A Study On Thrombophilia Markers Using The ePlex Platform
10/19/2005 5:12:09 PM
GeneOhm Sciences, Inc. (GSI) today announced the completion of the first collaborative study between GSI and The Cleveland Clinic Foundation. This study focused on several Single Nucleotide Polymorphisms (SNPs) in genes associated with venous thromboembolism (VTE). Using GSI's proprietary ePlex(TM) platform, six markers were simultaneously genotyped in multiplex reactions and compared to results observed on the Roche LightCycler(R). Of 269 single-point genotypes, each platform exhibited 100% concordant results.
comments powered by